BackEvogene Overview

Evogene Accounts Payable

Evogene's accounts payable is $460K.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$463000.00
21.79% YoYΔ $-129000.00 vs prior year quarter

Peer average

Loading

Evogene Accounts Payable History

Loading

Evogene vs. peers: Accounts Payable Comparison

Loading

Evogene Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Evogene (EVGN) FAQ

As of the most recent data (March 2026), EVGN shows a accounts payable of $460K. That compares with $590K in the prior-year period — down 21.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EVGN's accounts payable is now $460K (was $590K) — a 21.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Evogene is outperforming or lagging.

Tracking EVGN's accounts payable over time shows whether Evogene is scaling, shrinking, or reshaping that part of the business. The current reading is $460K That compares with $590K in the prior-year period — down 21.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Evogene's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $460K) with ownership activity and broader fundamentals.

Evogene's accounts payable is $460K; compare it with other Materials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.